berberine and Acute Myelogenous Leukemia

berberine has been researched along with Acute Myelogenous Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Cheng, M; Huang, C; Jia, PC; Li, HD; Li, J; Li, JJ; Liu, JY; Lv, XW; Niu, XN; Xu, JJ; Zhu, L1
Fan, X; Guo, L; Guo, Q; Huang, Z; Liu, W; Ma, W; Shen, Y; Wei, C; Yan, Q; Yang, Y1
Fei, J; Hu, H; Huang, G; Li, C; Liu, Y; Nie, H; Su, R; Wang, X; Wen, Z; Yang, J; Yin, Z; Zeng, X1
Gao, L; Gong, L; Li, J; Qiu, H; Shen, R; Shi, Z; Sun, H; Tian, Z; Yang, L; Zhang, G1
Du, W; Fan, L; Fu, B; Guo, L; Huang, S; Jie, S; Li, H; Liu, W; Wang, X; Zhu, J1

Other Studies

5 other study(ies) available for berberine and Acute Myelogenous Leukemia

ArticleYear
Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease.
    Laboratory investigation; a journal of technical methods and pathology, 2023, Volume: 103, Issue:4

    Topics: AMP-Activated Protein Kinases; Animals; Berberine; Ethanol; Fatty Liver; Leukemia, Myeloid, Acute; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Sirtuin 1; Sterols; Transcription Factors

2023
Berberine targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia with IDH1 mutation.
    Chinese journal of natural medicines, 2023, Volume: 21, Issue:2

    Topics: Berberine; Electron Transport; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Mitochondria; Oxidative Phosphorylation

2023
System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 117

    Topics: Animals; Berberine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Stem Cells

2023
Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
    Journal of nanobiotechnology, 2018, Oct-05, Volume: 16, Issue:1

    Topics: Absorption, Physiological; Administration, Oral; Animals; Antineoplastic Agents; Berberine; Cell Death; Cell Line, Tumor; Cell Survival; Cytarabine; Drug Interactions; Drug Liberation; Emulsions; Leukemia, Myeloid, Acute; Mice; Nanoparticles; Permeability; Phase Transition; Rabbits; Xenograft Model Antitumor Assays

2018
Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2008, Volume: 62, Issue:9

    Topics: Adolescent; Adult; Aged; Anticarcinogenic Agents; Berberine; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Child; Depression, Chemical; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplastic Stem Cells

2008